| Titre : | Patient Experiences of Medication Adherence: A systematic review and qualitative meta-synthesis. |
| Titre original: | Le vécu des patients à l'égard de l'observance médicamenteuse : une revue systématique et une méta-analyse qualitative. |
| Titre de série : | CHEPA Working paper, 15-01 |
| Auteurs : | M. VANSTONE ; F. BRUNDISINI ; D. HULAN ; McMaster University. Hamilton ON. CAN |
| Type de document : | Document de travail |
| Editeur : | Hamilton : McMaster University, 2014 |
| Format : | 36p. |
| Note générale : | Référence : réf. bibl. |
| Langues: | Anglais |
| Catégories : |
[BDSP5] Autres sciences de l'homme [NI] > Anthropologie > Représentation santé [BDSP5] Etudes méthodes et statistiques [NI] > Méthodologie > Enquête qualitative [BDSP5] Histoire de vie [BDSP5] Information & communication [NI] > Information > Nature information [NI] > Revue de littérature [BDSP5] Pathologie > Glande endocrine [pathologie] > Diabète [BDSP5] Psychologie > Personnalité > Vécu [BDSP5] Thérapeutique > Thérapeutique médicamenteuse > Observance thérapeutique |
| Résumé : | Background : Adherence to prescribed medication regimens is an important part of self- -management for patients with diabetes. This report synthesizes qualitative information on how patients respond differently to the challenges of medication adherence, suggesting avenues for future research and intervention to assist patients with this aspect of self---management. Qualitative and descriptive evidence can also illuminate challenges that may affect the success and equitable impact of medication adherence interventions. Objectives : To examine the challenge of medication adherence from the perspective of patients with Type 2 diabetes and to describe the barriers and facilitators to medication regimens reported by this group. Data Sources : This report synthesizes 86 primary qualitative studies to examine barriers and facilitators to medication adherence from the perspective of adult patients with Type 2 diabetes mellitus. Included papers were published between 2002 and 2013 and studied adult patients in North America, Europe, and Australia/New Zealand. Review Methods : Qualitative meta---synthesis was used to integrate findings across primary research studies. Results : Analysis identified that medication adherence should be considered within the context of an individual patient's life, with barriers identified in three categories: lived experiences, health beliefs and understandings, and practical considerations. Limitations : While qualitative insights are robust and often enlightening for understanding experiences and planning services in other settings, they are not intended to be generalizable. The findings of the studies reviewed here—and of this synthesis—do not strictly generalize to the Ontario(or any specific) population. This evidence must be interpreted and applied carefully, in light of expertise and the experiences of the relevant community. Conclusions : Medication adherence is an important part of improving clinical outcomes for patients with diabetes. Barriers to medication adherence are complex and individualized, reflecting the fact that each patient manages his or her medications in the context of his or her own life. A patient---centered approach to medication regimen should consider the unique circumstances, resources, and situation of the patient. A regimen which is responsive to the individual requirements of each patient may result in increased concordance with clinical recommendations. |
| En ligne : | http://www.chepa.org/docs/default-source/default-document-library/patient-experiences-of-medication-adherence-chepa-working-paper.pdf |